Botulinum toxin type a induces direct analgesic effects in chronic neuropathic pain
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Objective: Botulinum toxin type A (BTX‐A) has been reported to have analgesic effects independent of its action on muscle tone, possibly by acting on neurogenic inflammation. Such a mechanism may be involved in peripheral neuropathic pain. Methods: A possible direct analgesic effect of BTX‐A pain processing was investigated in 29 patients with focal painful neuropathies and mechanical allodynia using a randomized, double‐blind, placebo‐controlled design. Patients received a one‐time intradermal administration of BTX‐A (20–190 units) into the painful area. Outcome measures, evaluated at baseline, then at 4, 12, and 24 weeks, included average spontaneous pain intensity, quantified testing of thermal and mechanical perception and pain, allodynia to brushing (area, intensity), neuropathic symptoms, clinical global impression, and quality of life. Results: BTX‐A treatment, relative to placebo, was associated with persistent effects on spontaneous pain intensity from 2 weeks after the injection to 14 weeks. These effects correlated with the preservation of thermal sensation at baseline ( p < 0.05). BTX also improved allodynia to brush and decreased pain thresholds to cold, without affecting perception thresholds. There were sustained improvements in the proportion of responders (number needed to treat for 50% pain relief: 3.03 at 12 weeks), neuropathic symptoms, and general activity. Most patients reported pain during the injections, but there were no further local or systemic side effects. Interpretation: These results indicate for the first time that BTX‐A may induce direct analgesic effects in patients with chronic neuropathic pain independent of its effects on muscle tone and suggest novel indications for BTX‐A in analgesia. Ann Neurol 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Hospital Anxiety and Depression Scale
Zigmond, A. S., & Snaith, R. P. (1983) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1983.tb09716.x · Cited by 47,139
Persistent postsurgical pain: risk factors and prevention
Kehlet, H., Jensen, T. S., & Woolf, C. J. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68700-x · Cited by 4,086
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126
Prevalence of chronic pain with neuropathic characteristics in the general population
Bouhassira, D., Lantéri-Minet, M., Attal, N., Laurent, B., & Touboul, C. (2008) · Pain · doi:10.1016/j.pain.2007.08.013 · Cited by 1,745
Self-citationAlgorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,330
Development and validation of the Neuropathic Pain Symptom Inventory
Bouhassira, D., Attal, N., Fermanian, J., Alchaar, H., Gautron, M., Masquelier, E., Rostaing, S., Lanteri-Minet, M., Collin, E., Grisart, J., et al. (2004) · Pain · doi:10.1016/j.pain.2003.12.024 · Cited by 1,329
Self-citationTorrance, N., Smith, B. H., Bennett, M. I., & Lee, A. J. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.11.008 · Cited by 1,000
EFNS guidelines on pharmacological treatment of neuropathic pain
Attal, N., Cruccu, G., Haanpää, M., Hansson, P., Jensen, T. S., Nurmikko, T., Sampaio, C., Sindrup, S., & Wiffen, P. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01511.x · Cited by 880
Self-citationSV2 Is the Protein Receptor for Botulinum Neurotoxin A
Dong, M., Yeh, F., Tepp, W. H., Dean, C., Johnson, E. A., Janz, R., & Chapman, E. R. (2006) · Science · doi:10.1126/science.1123654 · Cited by 770
Subcutaneous administration of botulinum toxin A reduces formalin-induced pain
Cui, M., Khanijou, S., Rubino, J., & Aoki, K. R. (2004) · Pain · doi:10.1016/j.pain.2003.10.008 · Cited by 676
Cited by
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Attal, N., Cruccu, G., Baron, R., Haanpää, M., Hansson, P., Jensen, T. S., & Nurmikko, T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02999.x · Cited by 1,873
Self-citationNeuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
Baron, R., Binder, A., & Wasner, G. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70143-5 · Cited by 1,816
Neuropathic Pain: From Mechanisms to Treatment
Finnerup, N. B., Kuner, R., & Jensen, T. S. (2021) · Physiological Reviews · doi:10.1152/physrev.00045.2019 · Cited by 1,558
Dworkin, R. H., O'Connor, A. B., Audette, J., Baron, R., Gourlay, G. K., Haanpää, M. L., Kent, J. L., Krane, E. J., LeBel, A. A., Levy, R. M., et al. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0649 · Cited by 1,325
Aurora, S., Dodick, D., Turkel, C., DeGryse, R., Silberstein, S., Lipton, R., Diener, H., & Brin, M. (2010) · Cephalalgia · doi:10.1177/0333102410364676 · Cited by 1,047
The evidence for pharmacological treatment of neuropathic pain
Finnerup, N. B., Sindrup, S. H., & Jensen, T. S. (2010) · Pain · doi:10.1016/j.pain.2010.06.019 · Cited by 1,045
Dodick, D. W., Turkel, C. C., DeGryse, R. E., Aurora, S. K., Silberstein, S. D., Lipton, R. B., Diener, H., & Brin, M. F. (2010) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01678.x · Cited by 994
Allodynia and hyperalgesia in neuropathic pain: clinical manifestations and mechanisms
Jensen, T. S., & Finnerup, N. B. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70102-4 · Cited by 976
Diener, H., Dodick, D., Aurora, S., Turkel, C., DeGryse, R., Lipton, R., Silberstein, S., & Brin, M. (2010) · Cephalalgia · doi:10.1177/0333102410364677 · Cited by 960
Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms
von Hehn, C. A., Baron, R., & Woolf, C. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.02.008 · Cited by 800
Guidance on the management of pain in older people
(2013) · Age and Ageing · doi:10.1093/ageing/afs200 · Cited by 727
Complex Regional Pain Syndrome: Practical Diagnostic and Treatment Guidelines, 4th Edition
Harden, R. N., Oaklander, A. L., Burton, A. W., Perez, R. S. G. M., Richardson, K., Swan, M., Barthel, J., Costa, B., Graciosa, J. R., & Bruehl, S. (2013) · Pain Medicine · doi:10.1111/pme.12033 · Cited by 534
Moulin, D., Boulanger, A., Clark, A., Clarke, H., Dao, T., Finley, G., Furlan, A., Gilron, I., Gordon, A., Morley-Forster, P., et al. (2014) · Pain Research and Management · doi:10.1155/2014/754693 · Cited by 529
Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations
Edwards, R. R., Dworkin, R. H., Turk, D. C., Angst, M. S., Dionne, R., Freeman, R., Hansson, P., Haroutounian, S., Arendt-Nielsen, L., Attal, N., et al. (2016) · Pain · doi:10.1097/j.pain.0000000000000602 · Cited by 403
Self-citationAurora, S. K., Winner, P., Freeman, M. C., Spierings, E. L., Heiring, J. O., DeGryse, R. E., VanDenburgh, A. M., Nolan, M. E., & Turkel, C. C. (2011) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01990.x · Cited by 295
Mechanisms of Botulinum Toxin Type A Action on Pain
Matak, I., Bölcskei, K., Bach-Rojecky, L., & Helyes, Z. (2019) · Toxins · doi:10.3390/toxins11080459 · Cited by 267
Baron, R., Förster, M., & Binder, A. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70189-8 · Cited by 262
Blumenfeld, A., Silberstein, S. D., Dodick, D. W., Aurora, S. K., Turkel, C. C., & Binder, W. J. (2010) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2010.01766.x · Cited by 254
Attal, N., de Andrade, D. C., Adam, F., Ranoux, D., Teixeira, M. J., Galhardoni, R., Raicher, I., Üçeyler, N., Sommer, C., & Bouhassira, D. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00017-x · Cited by 253
Self-citationSubcutaneous Injection of Botulinum Toxin A Is Beneficial in Postherpetic Neuralgia
Xiao, L., Mackey, S., Hui, H., Xong, D., Zhang, Q., & Zhang, D. (2010) · Pain Medicine · doi:10.1111/j.1526-4637.2010.01003.x · Cited by 199
Assessing symptom profiles in neuropathic pain clinical trials: can it improve outcome?
Attal, N., Bouhassira, D., Baron, R., Dostrovsky, J., Dworkin, R. H., Finnerup, N., Gourlay, G., Haanpaa, M., Raja, S., Rice, A. S. C., et al. (2011) · European Journal of Pain · doi:10.1016/j.ejpain.2011.03.005 · Cited by 105
“One study using botulinum toxin type A found that the drug relieved only some dimensions assessed with the NPSI (burning pain, paroxysmal pain, evoked pains but not deep pain or paresthesia) (Ranoux et al., 2008).”
BackgroundSelf-citationBischoff, J. M., Petersen, M., Üçeyler, N., Sommer, C., Kehlet, H., & Werner, M. U. (2013) · Anesthesiology · doi:10.1097/aln.0b013e3182a2a243 · Cited by 53
Subcutaneous Botulinum Toxin for Chronic Post‐Thoracotomy Pain
Fabregat, G., Asensio‐Samper, J. M., Palmisani, S., Villanueva‐Pérez, V. L., & De Andrés, J. (2013) · Pain Practice · doi:10.1111/j.1533-2500.2012.00569.x · Cited by 35
New developments in the treatment algorithm for peripheral neuropathic pain.
de Leon-Casasola, O. (2011) · Pain Medicine · doi:10.1111/j.1526-4637.2011.01160.x · Cited by 32
Metadata
- Authors
- Ranoux, D., Attal, N., Morain, F., & Bouhassira, D.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2008-06-10
- Volume
- 64
- Issue
- 3
- Pages
- 274-283
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2019686332
- Cited by
- 459
- References
- 35
- FWCI
- 21.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.